CGMs for Wellness: A Data Toy or a Health Tool?

TL;DR

Continuous Glucose Monitors (CGMs) like Levels, Lingo, and the over-the-counter Stelo are now marketed to non-diabetics for 'metabolic health.' While they provide fascinating real-time data on how food affects your blood sugar, they also risk creating food anxiety. They are best used as a temporary tool for awareness rather than a permanent lifestyle accessory.

Key takeaways

• Continuous Glucose Monitors (CGMs), once only for diabetics, are now a rapidly growing consumer wellness trend.
• Key players include data-focused startup Levels and consumer-friendly devices from medical giants, Abbott (Lingo) and Dexcom (Stelo).
• Dexcom's Stelo gaining FDA approval for over-the-counter sales signals a major shift toward mainstream accessibility.
• CGMs provide real-time data on how food, exercise, and stress affect your blood sugar, which can inform healthier habits.
• A major risk is developing 'orthorexia' or food anxiety by misinterpreting normal glucose spikes as 'bad'.
• Glucose spikes after eating carbohydrates are a normal and necessary physiological function.
• These devices are best used as short-term educational tools, not permanent lifestyle accessories, ideally with professional guidance.

What's happening

There was a time, not long ago, when seeing a small, white disc affixed to someone's upper arm was an immediate tell. This person, you would assume, manages diabetes. The device, a continuous glucose monitor (CGM), was a piece of serious medical equipment, a lifeline for tracking blood sugar and managing insulin. Today, that same disc is just as likely to be spotted on a venture capitalist in a Patagonia vest, a yoga instructor between classes, or a tech CEO optimizing their lunch.

The CGM has officially crossed the chasm from clinical necessity to consumer wellness accessory. What was once exclusively for managing a chronic disease is now being marketed as a tool for unlocking 'peak performance,' 'metabolic health,' and 'personalized nutrition' for the generally healthy but perpetually curious. Startups with slick branding and venture backing have repackaged these medical devices, pairing them with sophisticated apps that turn your body’s metabolic data into a stream of scores, graphs, and actionable, if sometimes questionable, advice.

At the forefront of this movement are names that are becoming increasingly familiar in wellness circles: Levels, the data-heavy darling of the biohacking community; Lingo, the polished consumer play from medical device giant Abbott; and now Stelo, a device from competitor Dexcom that recently earned the FDA's blessing for over-the-counter sales. This shift signifies that CGMs are no longer a niche fascination but a mainstream product category poised for significant growth, asking a fundamental question: is this constant stream of data a revolutionary tool for well-being, or just a fashionable way to induce anxiety about a post-lunch apple?

Why it matters now

This trend is not happening in a vacuum. It’s the logical endpoint of the 'quantified self' movement, which has seen millions of people strap on rings and watches to track every step, heartbeat, and minute of sleep. The global wellness market, valued by the Global Wellness Institute at over $5.6 trillion, is fueled by a demand for personalization and data. Consumers are no longer content with generic advice; they want to know what works for their specific biology. CGMs promise to deliver exactly that, offering a direct window into one of the body’s most fundamental processes: energy regulation.

The market’s maturation is marked by the entry of the very companies that pioneered CGMs for diabetes. Abbott and Dexcom aren't just letting startups repackage their hardware anymore; they're building their own direct-to-consumer brands. Dexcom's Stelo receiving FDA approval for non-prescription use in the United States is a watershed moment. It removes a significant barrier to entry, moving the CGM from something you need a doctor’s sign-off for to something you can, in theory, pick up at a pharmacy. This influx of capital, competition, and accessibility is rapidly accelerating adoption, turning a niche curiosity into a scalable consumer health category.

The methodology

The landscape of consumer CGMs is dominated by a few key players, each with a slightly different philosophy and target audience. While the underlying sensor technology is often similar (or identical), the user experience, software, and cost structure vary significantly. Understanding these differences is key to determining if, and which, CGM might be a useful tool for your personal exploration.

Levels: The OG Biohacker's Toolkit

Levels was one of the first and loudest voices to position the CGM as a wellness tool for the masses, or at least the masses who listen to podcasts about longevity. Their product is not the hardware itself—they use sensors made by Abbott—but the software layer and community built on top of it. The Levels app is a dense, data-rich environment that logs your meals, scores them based on their glucose response, and offers deep analysis on concepts like glycemic variability and 'metabolic fitness.'

• Verdict: The most comprehensive data platform for serious self-optimizers who want to go deep on the science.
• For: Data-obsessed individuals, biohackers, and performance-focused athletes who are willing to spend time in the analytical weeds.
• Price Band: High. It involves a significant annual membership fee on top of the recurring cost of the sensors themselves, which are not included.

Abbott's Lingo: The Legacy Player's Pivot

Abbott, the manufacturer of the FreeStyle Libre sensors that companies like Levels use, has now entered the consumer ring directly with Lingo. Having honed its hardware for a decade in the medical space, Abbott's consumer offering is predictably polished. The branding is clean and accessible, eschewing some of the hardcore biohacker jargon in favor of broader 'metabolic health' language. The app focuses on a simple 'Lingo Count' and real-time coaching to help users flatten their glucose curves.

• Verdict: A slick, user-friendly entry from a trusted medical device giant that feels more like a consumer electronic than a medical device.
• For: The wellness-curious individual who wants a guided, less intimidating introduction to glucose monitoring and values the trust associated with a major healthcare brand.
• Price Band: Medium-High. Typically a subscription model that bundles the app and a regular supply of sensors.

A person applying a CGM sensor to their arm

Dexcom's Stelo: The Over-the-Counter Game Changer

Stelo, from Abbott's main rival Dexcom, represents the next phase of the consumer CGM market. It's the first CGM to receive FDA approval for over-the-counter sale in the US to adults who do not use insulin. This is a critical distinction. It's not for managing diabetes but expressly for the general wellness user. The sensor lasts for 15 days and sends data directly to a dedicated smartphone app. By removing the prescription hurdle, Dexcom is making a bold play to become the default, most accessible option for anyone curious about their metabolic data.

• Verdict: The most accessible and medically-vetted over-the-counter option, set to define the entry-level CGM experience.
• For: Anyone who wants to try glucose monitoring without committing to a long-term program or needing a doctor's visit.
• Price Band: Medium. Likely sold in packs of one or two sensors, making the upfront cost lower than subscription-based competitors.

The Data Itself: Signal, Noise, and Orthorexia

Perhaps the most important component to analyze is the data stream itself. A CGM provides a fascinating, minute-by-minute look at how your body responds to food, exercise, stress, and sleep. The problem is that not all data is created equal, and without context, it can be misleading. A post-meal glucose spike is not a sign of failure; it is a normal, healthy physiological response. Carbohydrates are broken down into glucose, which enters the bloodstream to be used as energy. That's metabolism.

The goal isn't a flat line, which would indicate a system that isn't working. The goal is a healthy, resilient response: a moderate rise and a steady return to baseline. The apps gamify this, encouraging users to keep their curves as flat as possible, which can inadvertently pathologize perfectly healthy foods like fruit and root vegetables. This relentless focus on 'scoring' meals can, for some, become a gateway to orthorexia—an unhealthy obsession with healthy eating. The data is a tool for awareness, but it's a blunt one. It can't differentiate between a glucose rise from a banana versus one from a can of soda.

What this means for you

So, should you get a CGM? The honest answer is: maybe, but with caution. If you are genuinely curious about how your body works and can approach the data with a mindset of detached observation, a CGM can be a powerful short-term educational tool. Wearing one for a month could teach you that your 'healthy' morning smoothie is spiking your blood sugar more than your evening meal, or that a 10-minute walk after lunch dramatically improves your afternoon energy levels. It can be an excellent catalyst for behavior change.

However, it is not a magic bullet. The data is just one piece of a vastly complex puzzle. It tells you nothing about nutrient density, inflammation, or your gut microbiome. Fixating on a single biomarker is reductive. If you're going to use a device like this, consider it an experiment with a defined end date. Use it to gain insights, then trust yourself to integrate those learnings without being tethered to an app. For a more nuanced interpretation of what your metabolic data means in the context of your whole life, the expertise of a human professional is invaluable. You can find vetted nutrition experts and health coaches on the Codex [/coaches] platform who can help you make sense of the noise. Or, to understand where to even begin your wellness journey, our AI-driven [/intake] can provide a personalized starting point.

Verdict

Continuous glucose monitors for non-diabetics are more than a passing fad, but they are not the panacea that some breathless marketing suggests. They represent a potent new category of wearable technology that offers an unprecedented level of insight into our internal environment. The utility, however, lies entirely with the user. Used wisely, as a temporary tool for education and awareness, a CGM can be transformative. Used unwisely, it can become an expensive source of anxiety and a catalyst for disordered eating. The data is real, but the wisdom is sold separately.

FAQ

Do I need a prescription for a CGM?

Historically, yes. However, with the FDA's approval of devices like the Dexcom Stelo for over-the-counter sale, some CGMs are now available without a prescription for general wellness use in adults not on insulin.

Does wearing a CGM hurt?

Application involves a spring-loaded applicator that inserts a very thin, flexible filament just under the skin. Most users report a slight pressure or a pinch during application, but it is generally considered painless to wear.

Is a glucose spike after a meal bad?

No, a temporary rise in blood glucose after eating is a normal physiological response, especially after consuming carbohydrates. The goal is not a flat line, but a healthy and efficient response where glucose levels rise moderately and return to baseline in a reasonable time frame.

How long do you wear a single CGM sensor?

Most consumer-focused CGM sensors are designed to be worn continuously for 10 to 15 days before they need to be replaced. After the specified period, you remove the old sensor and apply a new one.